Original Research

Onychomycosis in KwaZulu-Natal: Clinical spectrum, risk factors and fungal susceptibility

Jaya Jhoomuck, Yesholata Mahabeer, Antoinette Chateau
Journal of the Colleges of Medicine of South Africa | Vol 4, No 1 | a409 | DOI: https://doi.org/10.4102/jcmsa.v4i1.409 | © 2026 Jaya Jhoomuck, Yesholata Mahabeer, Antoinette Chateau | This work is licensed under Other
Submitted: 22 March 2026 | Published: 20 July 2026

About the author(s)

Jaya Jhoomuck, Discipline of Dermatology, Nelson R Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Yesholata Mahabeer, Department of Medical Microbiology, National Health Laboratory Service, Durban, South Africa; and, Discipline of Medical Microbiology, School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Antoinette Chateau, Discipline of Dermatology, Nelson R Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa; and, Department of Dermatology, Grey’s Hospital, Pietermaritzburg, South Africa

Abstract

Background: Although onychomycosis is common worldwide and often significantly impairs the quality of life of patients, local epidemiological and mycological data are lacking. We therefore investigated the risk factors, clinical features and mycological aspects of onychomycosis in KwaZulu-Natal.
Methods: This study had two components. In the retrospective arm, positive fungal nail cultures from 2018 to 2024 were analysed. Prospectively in 2025, clinical and mycological data were collated. Descriptive statistical methods were used to summarise the dataset.
Results: Out of a total of 301 patients, 229 patients with positive cultures were analysed. The retrospective analysis (n = 177) showed Candida species were the most common (66.7%), followed by moulds (13.6%) and Trichophyton species (11.9%). Prospectively, 124 patients were included; 51.6% females and 48.4% males with a median age of 58.0 years. Candida species (40.4%), moulds and Trichophyton species (25.0% each) were most frequent in 52 patients with positive cultures. All Candida species were susceptible to fluconazole. Most patients had subungual hyperkeratinisation. Immunosuppression (other than human immunodeficiency virus [HIV] infection and diabetes mellitus) was the most common risk factor.
Conclusion: Candida species were the commonest cause of onychomycosis; therefore fluconazole is an appropriate treatment modality. However, revision of the existing essential drug list is recommended to include itraconazole or terbinafine for patients with confirmed infection with moulds or dermatophytes.
Contribution: This is the first detailed analysis of onychomycosis in KwaZulu-Natal and contributes to the limited body of data in South Africa. Our results may be used to inform therapeutic recommendations.


Keywords

onychomycosis; fluconazole; demographics; risk factors; causative species; KwaZulu-Natal; South Africa

Sustainable Development Goal

Goal 1: No poverty

Metrics

Total abstract views: 613
Total article views: 1116


Crossref Citations

No related citations found.